Quality of Life Improves with Alemtuzumab Over 6 Years in Relapsing-Remitting Multiple Sclerosis Patients with or without Autoimmune Thyroid Adverse Events: Post Hoc Analysis of the CARE-MS Studies

  1. Bertolotto, A.
  2. Arroyo, R.
  3. Celius, E.G.
  4. Comi, G.
  5. Havrdova, E.K.
  6. Honeycutt, W.D.
  7. Hunter, S.F.
  8. Izquierdo, G.
  9. Kornek, B.
  10. Miller, T.
  11. Mitsikostas, D.D.
  12. Singer, B.A.
  13. Ziemssen, T.
  14. Chung, L.
  15. Daizadeh, N.
  16. Afsar, S.
  17. Hashemi, L.
  18. Senior, P.
Zeitschrift:
Neurology and Therapy

ISSN: 2193-6536,  2193-8253

Datum der Publikation: 2020

Ausgabe: 9

Nummer: 2

Seiten: 443-457

Art: Artikel

DOI: 10.1007/S40120-020-00191-7 GOOGLE SCHOLAR lock_openOpen Access editor
Datenquelle: Scopus